© 2004 by Oxford University Press
© 2004 Oxford University Press
EDITORIAL |
The Certainties and the Uncertainties of Ductal Carcinoma In Situ
Correspondence to: Monica Morrow, MD, Northwestern University Feinberg School of Medicine, Lynn Sage Breast Center, 251 East Huron St., Galter 13-174, Chicago, IL 60611 (e-mail: mmorrow@nmh.org)
| The first 10% of the full text of this article appears below. |
Ductal carcinoma in situ (DCIS) was an uncommon problem before the use of screening mammography, but it is estimated that 55 700 new cases of DCIS were diagnosed in the United States in 2003 (1). Our lack of understanding of the natural history of DCIS, coupled with treatment options ranging from excision alone to mastectomy plus tamoxifen therapy, has resulted in confusion among both women and their physicians regarding the selection of an appropriate management strategy. This is reflected in the study by Baxter et al. (2), in this issue of the Journal, who documented that between 1992 and 1999 the use of both mastectomy and axillary surgery for women with DCIS decreased, while treatment with excision alone remained common throughout the study period. The authors concluded
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Kuhl The Current Status of Breast MR Imaging * Part I. Choice of Technique, Image Interpretation, Diagnostic Accuracy, and Transfer to Clinical Practice Radiology, August 1, 2007; 244(2): 356 - 378. [Abstract] [Full Text] [PDF]
|
|